394 results on '"LaKind, Judy S"'
Search Results
2. 2,4-D and NHANES: Sources of exposure and identification of data gaps
3. Erratum: Current Breast Milk PFAS Levels in the United States and Canada: After All This Time, Why Don't We Know More?
4. PFAS in Breast Milk and Infant Formula--It's Time to Start Monitoring
5. Epidemiology of PCBs and neurodevelopment: Systematic assessment of multiplicity and completeness of reporting
6. Bridging the epidemiology risk assessment gap: An NO2 case study of the Matrix
7. A matrix for bridging the epidemiology and risk assessment gap
8. Cancer Cluster Investigations: Review of the Past and Proposals for the Future
9. Biomonitoring and Nonpersistent Chemicals—Understanding and Addressing Variability and Exposure Misclassification
10. Workgroup Report: Biomonitoring Study Design, Interpretation, and Communication-Lessons Learned and Path Forward
11. A Critical Review of Methods for Comparing Estrogenic Activity of Endogenous and Exogenous Chemicals in Human Milk and Infant Formula
12. Biomonitoring of Dioxins and Furans: Levels and Trends in Humans
13. Infant Exposure to Chemicals in Breast Milk in the United States: What We Need to Learn from a Breast Milk Monitoring Program
14. Urinary metabolites of volatile organic compounds of infants in the neonatal intensive care unit
15. Epidemiology for risk assessment: US Environmental Protection Agency quality considerations and the Matrix
16. Invited Perspective: PFAS in Breast Milk and Infant Formula—It’s Time to Start Monitoring
17. Methodological evaluation of human research on asthmagenicity and occupational cleaning: a case study of quaternary ammonium compounds (“quats”)
18. Per- and polyfluoroalkyl substances (PFAS) in breast milk and infant formula: A global issue
19. Interpreting biomonitoring data: Introducing the international human biomonitoring (i-HBM) working group's health-based guidance value (HB2GV) dashboard
20. Commentary: Systematic reviews and observational epidemiology: The more things change…
21. A Novel Application of Risk–Risk Tradeoffs in Occupational Health: Nurses’ Occupational Asthma and Infection Risk Perceptions Related to Cleaning and Disinfection during COVID-19
22. Epidemiology for risk assessment: US EPA guidance and the Matrix
23. Research on COVID-19 and air pollution: A path towards advancing exposure science
24. Chemical-induced asthma and the role of clinical, toxicological, exposure and epidemiological research in regulatory and hazard characterization approaches
25. Erratum: 'Infant Dietary Exposures to Environmental Chemicals and Infant/Child Health: A Critical Assessment of the Literature'
26. Elements to increase translation in pyrethroid epidemiology research: A review
27. Using Systematic Reviews and Meta-Analyses to Support Regulatory Decision Making for Neurotoxicants: Lessons Learned from a Case Study of PCBs
28. Do Human Milk Concentrations of Persistent Organic Chemicals Really Decline during Lactation? Chemical Concentrations during Lactation and Milk/Serum Partitioning
29. Childhood Asthma and Environmental Exposures at Swimming Pools: State of the Science and Research Recommendations
30. Guest Commentary : Environmental Chemicals in People: Challenges in Interpreting Biomonitoring Information
31. Current Breast Milk PFAS Levels in the United States and Canada: After All This Time, Why Don’t We Know More?
32. Temporal trends in bisphenol A exposure in the United States from 2003–2012 and factors associated with BPA exposure: Spot samples and urine dilution complicate data interpretation
33. Using the Matrix to bridge the epidemiology/risk assessment gap: a case study of 2,4-D
34. Does ozone inhalation cause adverse metabolic effects in humans? A systematic review
35. Utilizando revisoes sistematicas e meta-analise de apoio as decisoes regulatorias para neurotoxicos: licoes de um estudo de caso dos PCBs
36. Guidelines for the communication of Biomonitoring Equivalents: Report from the Biomonitoring Equivalents Expert Workshop
37. Guidelines for the derivation of Biomonitoring Equivalents: Report from the Biomonitoring Equivalents Expert Workshop
38. Biomonitoring Equivalents (BE) dossier for trihalomethanes
39. Public health interpretation of trihalomethane blood levels in the United States: NHANES 1999–2004
40. Perspective on serum dioxin levels in the United States: an evaluation of the NHANES data
41. Bisphenol A (BPA) daily intakes in the United States: Estimates from the 2003–2004 NHANES urinary BPA data
42. Environmental chemicals in people: challenges in interpreting biomonitoring information
43. Recent global trends and physiologic origins of dioxins and furans in human milk
44. Human breast biomonitoring and environmental chemicals: use of breast tissues and fluids in breast cancer etiologic research
45. How Many Urine Samples Are Needed to Accurately Assess Exposure to Non-Persistent Chemicals? The Biomarker Reliability Assessment Tool (BRAT) for Scientists, Research Sponsors, and Risk Managers
46. Hershey Medical Center Technical Workshop Report: Optimizing the design and interpretation of epidemiologic studies for assessing neurodevelopmental effects from in utero chemical exposure
47. Comparing United States and Canadian population exposures from National Biomonitoring Surveys: Bisphenol A intake as a case study
48. Distribution of Exposure Concentrations and Doses for Constituents of Environmental Tobacco Smoke
49. Use of Environmental Tobacco Smoke Constituents as Markers for Exposure
50. Exposure to Environmental Tobacco Smoke in the Workplace and the Impact of Away-From-Work Exposure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.